TITLE

Effect of Highly Active Antiretroviral Therapy on Hospitalization Characteristics of HIV-Infected Patients

AUTHOR(S)
Nuesch, R.; Geigy, N.; Schaedler, E.; Battegay, M.
PUB. DATE
September 2002
SOURCE
European Journal of Clinical Microbiology & Infectious Diseases;Sep2002, Vol. 21 Issue 9, p684
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
In order to determine the impact that highly active antiretroviral therapy (HAART) has on inpatients with HIV infection, HIV-infected patients hospitalized from 1994 to1999 at the Department of Internal Medicine, University of Basel, Switzerland, were investigated. During the observation period, 578 HIV-related hospitalizations occurred, and 502 charts from 262 different patients were available for evaluation. Analyses showed significant reductions in hospital mortality (from 13.2% to 6.5%) and length of stay for HIV-related admissions (from 16 to 11 days) in the post-HAART period, and the percentage of AIDS-related admissions decreased from 54.5% to 47.6%. However, the admission of HIV-infected patients to the intensive care unit increased from 6.3% to 11.8%, which could indicate that treating physicians have greater confidence in the outcome of HIV-infected patients due to better therapeutic options. Since the advent of HAART, the yearly number of admissions related to HIV dropped by 49% and HAART was administered often during hospital stay. By the end of the study period, death due to multiple HIV-associated diseases and wasting had disappeared.
ACCESSION #
15685800

 

Related Articles

  • The Survival Benefits of Antiretroviral Therapy in South Africa. April, Michael D.; Wood, Robin; Berkowitz, Bethany K.; Paltiel, A. David; Anglaret, Xavier; Losina, Elena; Freedberg, Kenneth A.; Walensky, Rochelle P. // Journal of Infectious Diseases;Feb2014, Vol. 209 Issue 4, p491 

    Background. We sought to quantify the survival benefits attributable to antiretroviral therapy (ART) in South Africa since 2004.Methods. We used the Cost-Effectiveness of Preventing AIDS Complications–International model (CEPAC) to simulate 8 cohorts of human immunodeficiency virus...

  • Mortality and Morbidity of HIV Infected Patients Receiving HAART: A Cohort Study. Panos, George; Samonis, George; Alexiou, Vangelis G.; Kavarnou, Garyfallia A.; Charatsis, Gerasimos; Falagas, Matthew E. // Current HIV Research;May2008, Vol. 6 Issue 3, p257 

    HAART has substantially decreased mortality and morbidity among HIV-infected patients. We retrospectively analyzed morbidity and mortality in a cohort of HIV-infected adult patients with prolonged and frequent follow up (1987-2006). The study was divided in pre-HAART and HAART period for...

  • Mortality and morbidity patterns among HIV patients with prognostic markers in a tertiary care hospital in southern India. Rajeev, A.; Sharma, A. // Australasian Medical Journal;May2011, Vol. 4 Issue 5, p273 

    Background Opportunistic infections are an important cause of morbidity and mortality in persons infected with HIV. In recent years, antiretroviral treatment (ART) and prophylaxis against various other opportunistic infections have contributed to a decrease in AIDS-related mortality. We...

  • Association between Highly Active Antiretroviral Therapy and Type of Infectious Respiratory Disease and All-Cause In-Hospital Mortality in Patients with HIV/AIDS: A Case Series. Báez-Saldaña, Renata; Villafuerte-García, Adriana; Cruz-Hervert, Pablo; Delgado-Sánchez, Guadalupe; Ferreyra-Reyes, Leticia; Ferreira-Guerrero, Elizabeth; Mongua-Rodríguez, Norma; Montero-Campos, Rogelio; Melchor-Romero, Ada; García-García, Lourdes // PLoS ONE;9/17/2015, Vol. 10 Issue 9, p1 

    Background: Respiratory manifestations of HIV disease differ globally due to differences in current availability of effective highly active antiretroviral therapy (HAART) programs and epidemiology of infectious diseases. Objective: To describe the association between HAART and discharge...

  • Overestimates of Survival after HAART: Implications for Global Scale-Up Efforts. Bisson, Gregory P.; Gaolathe, Tendani; Gross, Robert; Rollins, Caitlin; Bellamy, Scarlett; Mogorosi, Mpho; Avalos, Ava; Friedman, Harvey; Dickinson, Diana; Frank, Ian; Ndwapi, Ndwapi // PLoS ONE;2008, Vol. 3 Issue 3, p1 

    Background: Monitoring the effectiveness of global antiretroviral therapy scale-up efforts in resource-limited settings is a global health priority, but is complicated by high rates of losses to follow-up after treatment initiation. Determining definitive outcomes of these lost patients, and the...

  • Uptake of HIV testing and treatment in an isolated population with access to free and universal healthcare. Gillieatt, Sue J.; Mallal, Simon A.; Gillieatt, S J; Mallal, S A // International Journal of STD & AIDS;May2000, Vol. 11 Issue 5, p303 

    This Western Australian study analysed clinical information from 344 people with AIDS, and experiential data from a sample of 36 people with AIDS to investigate 2 relevant issues: the timing of HIV testing and uptake and experiences of HIV drug treatment. We found that the proportion of people...

  • Free antiretroviral treatment effective in Malawi.  // Infectious Disease News;Jun2008, Vol. 21 Issue 6, p39 

    The article reports on the results of a study on the efficiency of antiretroviral therapy in Malawi. It revealed that mortality rates of patients with HIV and AIDS have been reduced following the introduction of free antiretroviral therapy. According to researchers, the mortality rate was 9.8...

  • Beyond Core Indicators of Retention in HIV Care: Missed Clinic Visits Are Independently Associated With All-Cause Mortality. Mugavero, Michael J.; Westfall, Andrew O.; Cole, Stephen R.; Geng, Elvin H.; Crane, Heidi M.; Kitahata, Mari M.; Mathews, W. Christopher; Napravnik, Sonia; Eron, Joseph J.; Moore, Richard D.; Keruly, Jeanne C.; Mayer, Kenneth H.; Giordano, Thomas P.; Raper, James L. // Clinical Infectious Diseases;Nov2014, Vol. 59 Issue 10, p1471 

    Missed HIV care visits have independent prognostic value for clinical events beyond core indicators of retention in care. As this information is readily available and immediately actionable, missed HIV care visits should be incorporated into clinical, programmatic, and policy...

  • THE MIDDLE EAST AND NORTH AFRICA.  // AIDS Epidemic Update December 2003;2003, p26 

    The article discusses the prevalence of AIDS in the Middle East and North Africa in 2003. According to the authors, 55,000 people acquired HIV infection during the year, bringing to 600,000 the total number of people living with HIV/AIDS in the region. AIDS killed a further 45,000 people in the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics